The effect of proteasome inhibitor on nuclear factor kappa B activity in the lung of rats with postburn sepsis

Huinan YIN,Jiake CHAI,Yongming YAO,Yanqiu WU,Chuan'an SHEN,Zhiyong SHENG
DOI: https://doi.org/10.3760/j.issn:1671-0282.2006.10.007
2006-01-01
Abstract:Objective: To study the effect of ubiquitin-proteasome pathway inhibition on NF-κB activity and TNF-α secretion as well as myeloperoxidase (MPO) activity in the lung of rats with postburn sepsis. Methods: Rats with 30% total body surface area (TBSA) scald burn were injected lipopolysaccharide (LPS) into intraperitoneal to produce postburn sepsis. Seventy two Wistar rats were randomly divided into normal control group, postburn sepsis group, proteasome inhibitor N-Acetyl-leucinyl-leucinyl-norleucinal (ALLN) treatment group and NF-κB inhibitor Pyrrolidine Dithiocarbamate (PDTC) treatment group. NF-κB activation, tumor necrosis factor-α (TNF-α) protein expression, and pulmonary MPO activity were determined by electrophoretic mobility shift assay, enzyme-linked immunosorbent assay (ELISA), and spectrophotometric method, respectively. Results: NF-κB activity was markedly activated and reached its peak at 1h after burn and still kept high at 2 hours and then gradually reduced (P < 0.01). PDTC markedly decreased NF-κB activity at 1 h and 2 h after burn (P < 0.01), while ALLN markedly decreased NF-κB activity at 1 h (P < 0.01) but not at 2 h. TNF-α secretion was decreased at 2 hours after the administration of ALLN or PDTC in the lung (P < 0.01). Pulmonary MPO activity was significantly elevated at 2 h and 6 h (P < 0.01), but pretreatment with PDTC or ALLN markedly decreased the MPO activity at 2 h and 6 h (P < 0.01 ). Conclusion: Eearly treatment with inhibitor of ubiquitin-proteasome pathway might decrease the NF-κB activity and inflammatory reaction in the lung of rats with postburn sepsis.
What problem does this paper attempt to address?